|

Regorafenib 40 MG Oral Tablet Clinical Trials

1 actively recruiting trial

Pipeline

Phase 2: 1

Top Sponsors

  • Istituto Oncologico Veneto IRCCS1

Indications

  • Meningioma, Malignant1
  • Cancer1

Other1 trial

Regorafenib for Recurrent Meningioma (MIRAGE Trial)
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.